Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension.
about
The Renin-Angiotensin-aldosterone system in vascular inflammation and remodelingEndothelium-dependent contractions and endothelial dysfunction in human hypertensionCellular and molecular mechanisms of endothelial ischemia/reperfusion injury: perspectives and implications for postischemic myocardial protectionRole of Extracellular Vesicles and microRNAs on Dysfunctional Angiogenesis during Preeclamptic PregnanciesArginase as a Critical Prooxidant Mediator in the Binomial Endothelial Dysfunction-AtherosclerosisImpaired adenosine-mediated angiogenesis in preeclampsia: potential implications for fetal programmingNon-coronary atherosclerosisHigh resolution imaging of vascular function in zebrafishDiabetes, obesity, and hypertension may enhance associations between air pollution and markers of systemic inflammationIncreased Insulin following an Oral Glucose Load, Genetic Variation near the Melatonin Receptor MTNR1B, but No Biochemical Evidence of Endothelial Dysfunction in Young Asian Men and WomenRaloxifene, soy phytoestrogens and endothelial function in postmenopausal women.Exercise reduces arterial pressure augmentation through vasodilation of muscular arteries in humans.Comparison of skin microvascular reactivity with hemostatic markers of endothelial dysfunction and damage in type 2 diabetesAssociation between obstructive sleep apnea severity and endothelial dysfunction in an increased background of cardiovascular burden.Can a simple fingertip temperature measurement predict a cardiac event?Endothelial dysfunction as a target for prevention of cardiovascular disease.Ingestion of broccoli sprouts does not improve endothelial function in humans with hypertension.Oxidative stress and angiogenesis in primary hyperparathyroidism.Effects of statins on coronary and peripheral endothelial function in humans: a systematic review and meta-analysis of randomized controlled trials.Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009Functional imaging of working memory and peripheral endothelial function in middle-aged adults.Endothelial dysfunction and the risk of hypertension: the multi-ethnic study of atherosclerosis.Molecular insights and therapeutic targets for diabetic endothelial dysfunction.Hypertension, inflammation and T lymphocytes are increased in a rat model of HELLP syndromeEndothelial function as a functional expression of cardiovascular risk factors.L-arginine as a nutritional prophylaxis against vascular endothelial dysfunction with aging.Is reversal of endothelial dysfunction still an attractive target in modern cardiology?Risk factors associated with developing branch retinal vein occlusion among enrollees in a United States managed care plan.Cigarette smoking and erectile dysfunction: focus on NO bioavailability and ROS generation.Low testosterone concentration and atherosclerotic disease markers in male patients with type 2 diabetes.A randomized, double-blind, crossover, placebo-controlled trial of 6 weeks benfotiamine treatment on postprandial vascular function and variables of autonomic nerve function in Type 2 diabetes.Brachial artery constriction during brachial artery reactivity testing predicts major adverse clinical outcomes in women with suspected myocardial ischemia: results from the NHLBI-sponsored women's ischemia Syndrome Evaluation (WISE) Study.Testosterone and phosphodiesterase type-5 inhibitors: new strategy for preventing endothelial damage in internal and sexual medicine?Insulin resistance is an independent determinate of ED in young adult men.Assessing endothelial dysfunction in adolescents and young adults with type 1 diabetes mellitus using a non-invasive heat stimulusA control systems approach to quantify wall shear stress normalization by flow-mediated dilation in the brachial artery.Noninvasive Transcutaneous Monitoring in Long-Term Follow-Up of Patients With Thromboangiitis Obliterans Treated With Intravenous Iloprost.Gas what: NO is not the only answer to sexual function.Impact of olmesartan on blood pressure, endothelial function, and cardiovascular outcomes.Mechanisms and clinical consequences of untreated central sleep apnea in heart failure
P2860
Q21284671-1CD660A0-0108-42B3-B605-B75548075E9CQ24650963-E6804540-B869-431E-A241-6A0E65C2C212Q26751288-40719BB6-BC91-4863-8ADE-94F8B9D40540Q26752382-DCA87DFD-9460-49E0-A383-5BB7F7A6F3C1Q26991946-024FF838-56AB-4F53-9D36-875885B1C5B2Q27024603-69E03FD7-276A-42BD-B755-D8815497EF40Q27024872-B80FCD9F-2014-4051-B33A-1B321D91DAC5Q27321408-121BE611-AE63-48FC-91AD-3CD09AAE7685Q28199364-91C2807C-16DE-4BFB-8E18-B9C39E465692Q28546709-DF33295A-3894-432E-BD77-6DBB5A4229A7Q30838964-2001BDA2-7DD0-4AC1-A660-F56D4A88FA0CQ33320961-15A1CEAA-DBE1-428D-AA4F-5549D01A94A0Q33425250-B24BF200-3EBB-41A3-84D6-9A411F4EFB21Q33570289-F9F75B51-C1D3-491B-97D5-B23DCBCBA652Q33604174-57C4F0C8-BACA-463B-8213-17B114FB6726Q33610670-2CB1AD61-D920-4AD2-B3AC-674B6606E1BAQ33678871-FB57F25F-E7F6-42E8-BDC8-76B04AE743F6Q33708716-45058E32-35DD-4F44-8ABD-2AC5C4CD5E91Q33857895-20C2B676-9215-467D-B65C-410AAD6E480CQ33880303-8AD40D7B-E8CE-4859-A05E-C00C13DB395BQ33936235-CE6899A2-2756-45D6-B22F-0C9425463EE9Q33961005-8DE27C68-1201-4DC9-A16A-D35773AEAE34Q34022332-36BF2F83-CB20-4328-BD0C-DE2000F02A06Q34025660-8778F135-12C9-4772-A262-2E25964A7B60Q34027133-2B1035AB-A940-49CE-98D7-0D2D36E777FFQ34070390-2E36987B-9F41-4CCE-8F11-4AEDA078AC16Q34179077-57BFBB5C-2E8E-47F6-A642-6D1D24946AD4Q34257625-F3FB56C3-7C79-45D4-9B9E-1EF33CEB5558Q34412164-1DCE44CA-2AE2-4C57-B3E7-CB60F1DD3772Q34628361-05FE6262-5735-4C24-887D-32B80E510687Q34735842-8EF3D8C7-B533-45B7-828D-749B0BE0EF1EQ34994772-4481C058-0F97-4BDD-B1D2-8021EE8A7EC1Q35076387-5C846E9C-7483-4DE7-8248-F3C56E2AD0C8Q35082682-DF6BA328-C29E-4F29-84DB-FB992F2D5614Q35097133-280631BC-89FA-4AAF-AF51-01D0A1F4F9BDQ35097171-FAF24F92-D181-42CB-9998-8726B43DB956Q35203476-15B8F3F5-2D79-45E2-81B7-AF0E11A4B3F5Q35204833-04FFB28D-ABD5-4D2A-B234-F89BEE6C94FFQ35210513-71CFCCFD-3482-4A07-81DF-538B641D7FB9Q35335969-5C3C7A37-9A30-45F9-A870-3E99C9C9EB53
P2860
Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Endothelial function and dysfu ...... opean Society of Hypertension.
@ast
Endothelial function and dysfu ...... opean Society of Hypertension.
@en
type
label
Endothelial function and dysfu ...... opean Society of Hypertension.
@ast
Endothelial function and dysfu ...... opean Society of Hypertension.
@en
prefLabel
Endothelial function and dysfu ...... opean Society of Hypertension.
@ast
Endothelial function and dysfu ...... opean Society of Hypertension.
@en
P2093
P921
P1476
Endothelial function and dysfu ...... opean Society of Hypertension.
@en
P2093
Achille C Pessina
Andrea Natali
Ann Donald
Antonio Salvetti
Damiano Rizzoni
David J Webb
Ele Ferrannini
Gian Paolo Rossi
Hanspeter Brunner
James J Oliver
P304
P356
10.1097/00004872-200502000-00001
P577
2005-02-01T00:00:00Z